Braid implant delivery systems

Information

  • Patent Grant
  • 9675482
  • Patent Number
    9,675,482
  • Date Filed
    Wednesday, May 13, 2009
    17 years ago
  • Date Issued
    Tuesday, June 13, 2017
    9 years ago
Abstract
Embolic implants delivery systems and methods of manufacture and delivery are disclosed. The devices can be used for aneurysm and/or fistula treatment. The designs offer low profile compressibility for delivery to neurovasculature, while maintaining advantageous delivery and implant detachment control features.
Description
FIELD OF THE INVENTION

The subject matter described herein relates generally to systems, devices and methods for the delivery of textured (e.g., braided or woven) medical implants.


BACKGROUND

Mainstream clinical practice in endovascular treatment of intracranial aneurysms has changed little since the 1990's when vasooclusive coil use became widespread. Certainly, improved catheters and other auxiliary devices (e.g., stents) have helped make coiling procedures safer and/or more effective. However, the art in achieving adequate and appropriate aneurysm coil packing is best accomplished by the most highly skilled physicians.


Where practicable, aneurysm exclusion by cover-type devices (e.g., as described in U.S. patent application Ser. No. 12/397,123 to the assignee hereof may be preferred. Certain other groups are attempting to shift the paradigm away from intra-aneurysm coil packing to achieve embolization via deployment of an extra-aneurysm flow disruptor/diverter stent in the parent vessel. These densely braided devices and/or multiple braid devices layered upon one another are placed in the parent vessel across the neck of an aneurysm with the intent to alter hemodynamics so as to effect embolization.


US Patent Publications 2006/0271149 and 2006/0271153, assigned to Chestnut Medical Technologies, Inc., disclose delivery systems such braid-type stents. In one example system, a coil socket holds the distal end of the implant until this end is released during delivery catheter retraction with grippers holding the proximal end of the implant. These grippers are able to maintain contact with the proximal end of the implant through compression by the delivery catheter sleeve surrounding the grippers. Upon sleeve withdrawal, the grippers release the proximal end of the stent.


System miniaturization of the referenced system(s) is limited by the gripper configuration. Also, the lack of an active release mechanism for detachment from the distal socket presents issues of inadvertent deployment and/or non-optimal control.


Accordingly, there remains a need for each of more robust/reliable and/or more compact systems for advanced braid-type implant delivery. The present invention offers such systems with various advantages as presented herein and others as may be apparent to those with skill in the art.


SUMMARY OF THE INVENTION

The systems, methods and devices described in this section and elsewhere herein are done so by way of exemplary variations or embodiments. These examples are provided to aid in the description of the inventive subject matter and are in no way intended to limit the inventive subject matter beyond the express language of the claims.


The implant is preferably (i.e., has been selected as but is not necessarily) a stent or stent-like device and is held onto the delivery system by one or more releasable tubular covers. Each such cover is typically limited in length to envelop a relatively short length of the implant. Overlap between the members (i.e., cover and implant) is typically between about 1 mm and about 5 mm. More preferably, the overlap is between about 1.5 mm and about 3 mm. Accordingly, the cover(s) can be characterized as mini-sheath(s).


Implant release from the delivery system is accomplished by rupturing, tearing or otherwise splitting the mini-sheath cover(s). The cover(s) may be perforated or notched to promote breakage/rupture/tearing upon application of an expansive force.


Each mini-sheath is opened by expansive mechanical action generated by retraction of a core member. The core member may be user-actuated from a handle, by shape memory alloy (SMA) action upon heat application, or operate otherwise.


The expansion action is transmitted through the implant to force open the cover. In some examples, a sledge or wedge-type feature is pulled under the implant, thereby expanding it against the cover. In other examples, an expandable body under the implant forces the cover to open. Some examples described herein rely on both types of action.


The expander (e.g., in the form of a wedge or an expandable body) may contact the implant directly. Alternatively, an intermediate layer of material may be provided. Such a layer can be used to avoid implant damage, where the intermediate layer or member takes any abrasion, etc. along its inner surface—in effect shielding the implant matrix—and expands in unison with the implant to open the cover. The intermediate layer may also, or instead, be selected to provide a surface against which the implant is frictionally locked when constrained by the cover.


Such a lock relies on a high degree of surface friction between the implant and an underlying surface to resist longitudinal/axial motion of the implant (in its contracted state) along the longitudinal axis of the delivery device or sleeve. Substantial surface friction between implant and the underlying surface will prevent the implant from sliding relative to the underlying surface, preventing the implant from decreasing in length (i.e., foreshortening) and radially expanding. Although the term “lock” can be used, it should be understood that the implant is not locked from all movement in an absolute sense, as the implant can be forced from the lock should sufficient force be applied to overcome the surface friction. Rather, the implant is preferably locked in place sufficiently to resist the implant's own bias towards expansion (if any), to resist bias applied by a secondary expansion device (if any), to resist forces applied against the implant while maneuvering within the patient's vasculature (e.g., forces applied either by the delivery device or the patient's vasculature or blood flow), and/or to resist forces applied to the implant during any loading, unloading, or deployment procedures. Of course, one of skill in the art will appreciate that the degree of surface friction necessary to achieve the state of frictional lock will depend on the specific delivery device implementation and intended application(s).


When a frictional lock is relied upon to retain the implant on the delivery system until release, the implant preferably has textured surfaces (which may be continuous or disconnected) where it is intended to be secured to the delivery system by the mini-sheath(s). The surface(s) is/are preferably present about the entire inner periphery of the implant, but can also be located in limited regions generally corresponding to the interface regions of the sleeve.


In a preferred implementation, both the intermediate body and the implant comprise braid. However, other textured surfaces can be formed on either body by altering its surface to create a textured pattern, e.g., by etching, grinding, sanding, and the like. Still other textured surfaces can be formed by applying a high-friction coating to the body. Of course, any combination of these can also be used (e.g., a braid implant on a patterned underlying surface, etc.). Other optional details and discussion of the frictional interface between the implant and delivery system body may be taken from U.S. patent application Ser. No. 12/412,731, filed on Mar. 27, 2009 and titled “Friction-release Distal Latch Implant Delivery System and Components,” which is incorporated by reference for this purpose.


In another variation, instead of using a frictional lock generated between the implant and an underlying member to maintain the implant on the delivery system, an interlocking approach with the mini-sheath may be relied upon. In one example, the mini-sheath may comprise heat shrink that is entrained with the implant. Such interlocking may be assisted by vacuum forming while shrinking.


The interlock may alternatively, or additionally, be improved by including interface features on/in the implant around which the heat shrink forms. In an example where the implant comprises braid, some or all of the ends of the braid may be formed into ball ends (e.g., by laser application to from 0.003-0.005 inch diameter bodies) that the heat shrink can grasp. As a corollary advantage, these bodies may be radiopaque. Alternatively, radiopaque bands or coils that are crimpled, welded, soldered or otherwise affixed the implants ends could serve as retention features for the mini-sheath(s). These may be affixed only at the ends, or at intermediate points (e.g., to indicate a central section of increased density or any included cover).


In a preferred embodiment, the implant is a braided device with a braided surface about its entire exterior. The implant's number of wires, braid angle, pore size, profile, diameter, etc. may range in size. The braid may be metallic (as in NiTi, St. Steel, CoCr, other Ti and/or Zirconium alloy. etc.), polymeric, of hybrid construction or otherwise. Preferred variations may be formed of Nitinol. The alloy is preferably superelastic at body temperature. The metal may be a binary alloy or a ternary alloy to provide additional radiopacity. Alternatively, platinum or tantalum DFT Nitinol or platinum or tantalum wires may be included in the braid.


The density of the device is paramount in applications where braid itself is intended to affect blood flow, allowing thrombosis outside the implant to occlude a site. High density braid/mesh is typically required for such applications. Namely, braid having at least about 48 ends, typically set at about 90 degrees or greater, in diameters from about 4 to about 8 mm may be employed. At larger diameters (e.g., about 6 mm to 12 mm or more), more wire ends (e.g., common braider-size multiples of 64, 72 or 96) may be employed in forming the implants. Still higher typical wire counts may be employed. Moreover, 3-D braiding technology (such services are provided by 3Tex, Inc.) may be employed in forming the implant braid matrix.


A range of wire sizes or combination of wire sizes may be employed, typically ranging from about 0.0008 to about 0.0015 inch, and up to about 0.003 inches depending on desired delivery profile. A single braid tube may have all wires the same diameter, or may have some wires of a slightly thicker diameter to impart additional strength to the braid layer. The thicker wires impart greater strength to the implant without significantly increasing the device delivery profile, with the thinner wires offering some strength while filling-out the braid matrix density.


At least when employing Nitinol wire, to improve implant wire corrosion resistance and/or biocompatibility after any heat setting shape, the implants may be etched in “AYA” Sulfamic Acid solution, then passivated in Nitric acid solution. Alternatively or additionally, pre-etched and/or polished wire may be employed in braiding the implant matrix. Shape setting the braid in the implant shape may be performed in an oven/furnace, a fluidized bath or salt pot. All such processing is within the knowledge of those with ordinary skill in the art.


In some cases, the braid may incorporate polymeric fibers into the braid matrix—biodegradable (e.g., PLA/PGLA) or otherwise. Likewise, while the implants advantageously comprise include polymeric fill fiber, the entire braid may instead comprise polymer—especially high strength biodegradable polymer such as MX-2 (MAX-Prene), synthetic absorbable monofilament (90/10 Glycolide/L-Lactide) and/or G-2 (Glycoprene), synthetic absorbable monofilament (Glycolide (PGA), ε-Caprolactone (PCL), Trimethylene Carbonate (TMC) Copolymer) that is heat set into shape (e.g., at 110 degrees centigrade for an hour).


Whatever the material, the braid may be uniform, or it may be configured with a higher density center “patch” or circumferential section. If so, such a section will typically be located at the center of the device. Or, it may be offset distally. Moreover, a coating—such as urethane, etc. may be set over the implant in similar fashion. Still further configurations of implants having grafts, coatings (e.g., lubricious, drug-eluting, and the like) or other non-textured surfaces present on the exterior of the implant are possible. See, e.g., U.S. Pat. No. 4,416,028 to Eriksson, et al. Coatings, such as those available through NiCast, Inc. (Israel) or Medical Device Works (Belgium), may be used for such purposes, as well as others. Hydrogel coating also offers an appealing option, such as a hydrogel-based polymer network capable of entrapping therapeutic agents as described in U.S. Pat. No. 6,905,700 to Won et al.


The implant may include radiopaque markers as described above, or as described in either of U.S. patent application Ser. Nos. 12/412,731, filed on Mar. 27, 2009 and titled “Friction-release Distal Latch Implant Delivery System and Components,” or 61/177,847, filed on May 13, 2009 and titled “Absorbable Braid Implants and Delivery Systems,” each incorporated herein by reference in its entirety.


The implant is expandable from a contracted state to an expanded state, and preferably self-biased towards the expanded state (i.e., “self-expanding” as understood by those with skill in the art. Generally, expansion results in lengthwise shortening of the implant. Especially in braid-type implants, holding the end portions of the implant stretched apart from each other (as in at least one exemplary variation herein) can cause the implant to be maintained in a contracted state, without the need to radially restrain the entire implant (such as with a full body sheath).


Certain variations of the subject invention take advantage of this action. One such example releasably captures both ends of the implant so as to offer potential for independent navigation, especially when an optional atraumatic tip is incorporated in the design. Precision placement of the implant is achieved by predictable mini-sheath release upon rupture by contact with an inner floating wedge. By contracting the system, the floating wedge contacts each mini-sheath region at substantially the same time. However, the mini-sheath regions can be staged to release independently, for example, by using sheaths with varying thicknesses or by other means readily apparent to those of ordinary skill in the art,.


System flexibility can be optimized by using multi-segment (e.g., rings) wedge members. Alternatively, a selectively slit hypotube (e.g., Nitinol, resembling a segment of a SYNCHRO guidewire) or a coil spring (e.g., stainless steel or Nitinol) may be used. The coil spring can be tightly packed or include gaps that bottom-out upon compression. In any case, the ends of the spring are optionally be held together (e.g., by soldering) or set within jacket(s).


However constructed, the wedge member(s) may underlie a braid shaft—preferably attached adjacent an atraumatic tip, and running the full length of the delivery system. As discussed above, such a braid shaft offers an advantageous interlock with a braid implant to provide for robust stretch to a reduced diameter profile. Still further, the section of braid under the implant may be used to provide a mechanical expansion “balloon” effect to assist in splitting the mini-sheaths when compressed.


In an alternative construction, no wedges are provided, but such a braid expander is relied upon alone to open the mini-sheaths. Likewise, other constructions that expand when axially compressed are contemplated for rupturing the implant covers, including: coils, volume-incompressible polymer bodies (e.g. one or more urethane tubes), micro-machined (e.g., etched, EDM or laser-cut) metal lattices, etc.


Regardless, when deployed—as typical—in a vessel undersized relative to the implant, the system offers the potential for unique operation. In one mode of delivery, the stent is compressed until it reaches the vessel wall. After advancing the implant to a treatment site, the implant is compressed to achieve tissue apposition. With the body of the implant so-anchored, the end being moved (typically the distal end is retracted and the proximal shaft held stationary) causes the braid to evert and roll inward.


Upon release, the result is an implant having a substantially predictable (user selected) in-situ length, with a double-layer section of the braid. Such a feature is unique to delivery of braid-type implants because their length is typically dictated by vessel diameter. The current system, instead, allows not only for more precise placement than known delivery systems (typically sheath-based), but also a specified final implant length. In another mode of delivery, sizing may be selected to simply provide one layer. Either way, maximum braid density (e.g., as useful for flow-disruption/occlusion application) is achievable through the compressed delivery of the braid implant.


In an alternative configuration, the delivery system includes only one implant release latch. Such a device will be used in coordination with a microcatheter.


The latch may be configured for the proximal end or the distal end of the implant. In any case, precision placement of the implant is once-again achieved by predictable mini-sheath release upon its rupture. The rupture may be driven by a wedge member, an expandable braid or coil section, other means or a combination of such means.


However configured, to facilitate loading into a microcatheter for navigation to a treatment site and use, a loading sheath may be provided over at least a portion of the implant as typical. To assist in tracking within the catheter, delivery system may include a passive socket in which to receive the distal end of the implant and/or include a floppy tip.


Some of the delivery system architectures advantageously incorporate a braided tube that runs substantially the length of the system. With a jacket over the proximal portion, the construction provides a stable shaft. The jacket for the braided shaft may simply be an extension of the mini-sheath heat shrink material. At least one distal section of this braid is exposed to serve at least as a frictional interface member with the implant. In one example, it is only the interface. In another example, it provides both the implant interface and one or more expander element(s).


A jacketed braid shaft can be configured to be highly pushable, torqueable and kink-resistant. Moreover, in a braided configuration, the composite sleeve can have its PIC (Per Inch Crosses) varied along its length to provide enhanced distal flexibility. In other words, the sleeve may be tuned/modified as a catheter-like subcomponent of the system. In an alternative configuration, an elongate polymeric, metallic or metal alloy shaft can be used with section to interface with the implant.


Similarly, the core member can also be configured for enhanced flexibility. For example, the core member may have one or more successively tapered regions near or adjacent to its distal end, like a typical guidewire. In some examples, the core member has column strength (i.e., as in a wire) to allow tip extension; in others, it may be a tensile-capable member alone (e.g., as in a fiber or yarn). Both the core member and the sleeve can comprise an elastic or superelastic material such as stainless steel, NiTi, CoCr, other alloys, polymeric materials, and the like.


The sleeve jacket and/or implant restraint sheaths can, for example, be formed by heat-shrinkable tubing. The heatshrink for the covers, and the jacket described above, may be PE (polyethylene), PET (polyester), or the like. PI (polyamide), FEP, PEEK and other materials may also be advantageously employed in some cases. The mini-sheath/sleeve may be perforated or notched to promote breakage/rupture.


It is typically thin-walled heat shrink (e.g., about 0.0003 to about 0.0005 inch wall thickness PET). With or without the underlying braid frictional lock “Velcro” effect (and instead using a discrete proximal shaft comprising, e.g., PEEK or Nitinol) the mini-sheaths preferably comprise heat-shrink tubing that recovers to engage the implant. Thin wall (e.g., about 0.001 inch or less) PET is suitable for such retention and release as shown and described. Still, other materials may be used for the mini-sheaths, just as any suitable conventional material may be employed for the core member (e.g., NiTi, stainless steel) and other system components including those referenced above.


Depending on the device configuration, the delivery system inserted into the patient's vasculature may be directly navigated to a treatment site using conventional techniques just as if it were a guidewire. Alternatively, it may simply be passed through a catheter after exchange with a guidewire. Accordingly, for neurovascular applications, the system is advantageously sized to cross either an 0.021 or 0.027 inch microcatheter. The device is feasibly made with as small as about an 0.018 inches diameter. It may still be useful at larger sizes (especially for other applications—such as in the coronary or peripheral vasculature) as well.


After advancement to the treatment site, the implant is delivered by releasing or disengaging the implant. The implant may be so-delivered for a number of purposes. With a braided stent, at higher densities, it may be used to disrupt/divert the flow to treat an aneurysm or fistula. The implant may be delivered across a lateral wall aneurysm to effect flow disruption alone or with multiple devices. It may be also be used as a “coil jailer” by first trapping a microcatheter between the stent and a vessel wall and delivering coils into an aneurysm. It could be placed along one branch of a bifurcation to disrupt flow to a bifurcation/trifurcation aneurysm or offer a platform for retaining coils therein. It may be used as a liner, followed by placement of a tube-cut stent within it when stenting diseased saphenous vein grafts.


Other possibilities exist as well or will be apparent to those of ordinary skill in the art. The inventive subject matter provided herein includes these methods, systems and devices for practicing these methods, and methods of manufacturing those systems and devices.





BRIEF DESCRIPTION OF THE FIGURES

The details of the inventive subject matter set forth herein—both as to structure and operation—may be appreciated, in part, by study of the accompanying figures, in which like reference numerals may refer to like parts. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the subject matter. Moreover, all illustrations are intended to convey concepts, where relative sizes, shapes and other detailed attributes may be illustrated schematically rather than literally or precisely. Variation from the embodiments depicted is, of course, contemplated. Moreover, details commonly understood by those with skill in the art may be omitted as will be understood in review of the figures. Of these:



FIGS. 1A and 1B are partial side views depicting an example embodiment of the implant delivery system with an implant attached to and released from the system, respectively;



FIGS. 2A and 2B are partial side views depicting another example embodiment of the implant delivery system during progressive stages of deployment;



FIGS. 3A-3C are partial side views depicting yet another example embodiment of the implant delivery system during progressive stages of deployment;



FIG. 4A-4C depict different wedge components as may be employed in the delivery systems, especially that shown in FIGS. 3A-3C;



FIGS. 5A and 5B are detail illustrations of various mini-sheath/cover construction options to facilitate release;



FIG. 6 is another delivery system detail illustration which concerns component spacing to ensure cover release from the implant;



FIG. 7 is a partial side view of a one-sided detachment system related to the double-sided system in FIGS. 3A-3C in it use of a wedge member and expandable braid section for cover release;



FIG. 8 is a partial side view of another one-sided wedge-plus-braid expander type system;



FIG. 9 is a partial side view of a system like that presented in FIG. 7 but without an expansion wedge;



FIG. 10 is a partial side view of a system like that presented in FIG. 8 but without an expansion wedge;



FIGS. 11A and 11B are partial side views depicting an embodiment of the implant delivery system utilizing a compactable coil for cover release with an implant attached to and released from the system, respectively; and



FIGS. 12A-D are side views depicting an exemplary embodiment of the implant delivery system at different stages of implant deployment in treating an aneurysm.





In these views, elements that are contained within other elements are shown in profile with broken lines. However, though sometimes partially obscured, the implant profile is illustrated using an “x x x x x” pattern for the sake of clarity.


DETAILED DESCRIPTION

Various exemplary embodiments of the invention are described below. Reference is made to these examples in a non-limiting sense. They are provided to illustrate more broadly applicable aspects of the present invention. Various changes may be made to the invention described and equivalents may be substituted without departing from the true spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein.


Turning to FIG. 1A, it shows an implant delivery system 10 including an implant 12 comprising braid and having proximal 14 and distal ends 16 and a detachable pusher 20. An elongate sleeve 22 defines the pusher body. A core member 24 within the sleeve is connected to a wedge band 26. It may terminate at the wedge band or extend beyond it as shown. The core member 24 is optionally a wire (e.g., Stainless Steel or Nitinol), with one or more steps or taper as shown to offer graduated flex performance at least toward the distal end of the pusher 22 (up to or past the band 26). The band 26 may be cut from hypotube and be solder, welded or otherwise connected to the wire. It advantageously comprises steel or another hard material to avoid galling from contact with the braid. Alternatively, the “band” may comprise a few turns of a coil affixed to the core wire 24.


Sleeve (pusher) 22 comprises a liner 28 (e.g. PTFE lined Polyimide), tubular braid 30 (e.g., Stainless steel or Nitinol) and a jacket 32 (e.g., PET shrink tubing). Sleeve braid 30 extends under the implant proximal end 16, optionally, to terminate beyond core member 24 with a polymeric soft tip 34.


Mini-sheath or cover 36 holds the implant in a state of frictional lock with braid layer 30 along an overlap zone 38. This engagement is maintained until the core member 24 is withdrawn as illustrated in FIG. 1B. This action drives the wedge 26 under the engaged portion of the implant causing it to expand and tear, crack or otherwise rupture cover 36 open. Self-expansion of the implant effects release, and/or the pusher is simply withdrawn, to relieve any further interference. To ensure disengagement before removal, a 90 to 180 degree turn of the system may be advisable because the cover will typically (though not necessarily) split only along one side. Even without the turn, however, the lock holding the implant to the pusher is released allowing withdrawal with the implant in place.


Because the core member 24 in this variation of the invention is actuated only in tension, it may comprise a polymeric filament of fiber (e.g., Vectran or Spectra fiber), in which case the core member 24 is advantageously knotted to retain band 26, with optional potting with glue (e.g. 4014 LOCTITE). Delivery system flexibility can be maximized in this fashion, with any changes in stiffness developed along the body of the pusher (e.g., by changes to the braid and/or jacketing).



FIGS. 2A and 2B show a variation of the system in FIGS. 1A and 1B in which the intermediate braid layer 30 extends to secure a coil tip 40 and a cap or socket 42 for the implant distal end 16. For attachment to the coil tip 40, some of the braid wires may be trimmed-out with the remainder acting as a core to the tip. Such a tip may improve device tracking in a catheter. Setting the distal end of the implant in a socket may offer similar advantages.


When inside a catheter 44 (transferred thereto via a loading sheath as conventionally accomplished) the distal end of the implant 12 is protected within the cap 42. Upon exit from the catheter 44, the implant 12 is partially unconstrained and is able to expand so as to pull-out of the socket 42. Because no distal lock is provided in this variation of the invention, the cap 42 may comprise any of PI, PET or other tubing. No shrink onto the implant is necessary or desirable.


Braid extension 46 is optionally covered by a jacket 48 (e.g., with PTFE or PET shrink tubing or otherwise) to maintain dimensional stability of this body. Extending the jacket 48 underneath the distal end 16 of the implant 12 may also help ensure release as intended and illustrated in FIG. 2B when the implant 12 is free of the catheter 44.



FIGS. 3A-3C are partial side views depicting yet another example embodiment of the implant delivery system during progressive stages of deployment. While the previous examples only held one end of the implant in a locked arrangement, this delivery system 100 releasable captures both ends of the implant.


In this case, atraumatic tip 102 is connected to core wire, or member, 104 received within sleeve 106. Braid extension section 46 is preferably similarly attached. In this manner, when the core member 104 is withdrawn (compare FIG. 3A and FIG. 3B), the braid extension section 46 expands. This expansion may serve either of one or two purposes. In the variation shown, it may simply provide clearance for the floating expander wedge member(s) 108, allowing them to move into position to force open each of the proximal and distal covers 110, 112 (in a similar fashion to that described in reference to FIGS. 1A and 1B. Still further, braid section 46 can itself operate as an expander to open the covers 110, 112.


In any case, when the compressive action continues (by withdrawal of core member 104 and/or advancement of sleeve/shaft 106), the wedges 108 are driven fully under the covers 110, 112 to break them open and allow implant release. Cover release may occur substantially simultaneously. Alternatively, the action can be staged. In some applications it may be desirable to open the proximal end first; in others the distal first (especially for potential recapture purposes).


One way in which to accomplish sequential release is to utilize different thickness material, different type of material and/or vary such parameters as discussed in connection with FIGS. 5A and 5B, below, so that one cover is more freeable than the other.


In any case, it will be appreciated that a unique feature of delivery system 100 is that two release points are actuated by a single user input. This approach allows for minimizing delivery system profile as compared to a system that might include additional concentric layers to achieve similar two-sided functionality.


Indeed, minimizing the crossing profile for such a system can be especially useful in instances where it is intended to be used as a navigable delivery system in itself, as an interventionalist would employ a guidewire. Either by actively extending the core wire or by originally locking it into such a configuration during manufacturing, a “wire-like” delivery system is offered as shown in FIG. 3A. Given its (optional) tip-to-tail braid construction and the full-length core wire, the system can be optimized for such use. Excellent torquability is possible given that there need be no joints. Nor are their any performance-sapping component crossovers. The system is arranged in a completely concentric fashion in the example shown.



FIG. 4A-4C depict different wedge components as may be employed in delivery systems 100. FIG. 4A shows multiple bands 114. The bands may be independent (as shown) or interlocked in puzzle-piece fashion. FIG. 4B shows a coil spring 120. Turns 122 of the coil end are stabilized by soldered or welded zones 124. FIG. 4C shows a slit (e.g., by laser cutting or otherwise) hypotube 126. All of these options can provide excellent flexibility, while offering adequate resistance to compression during system actuation in order to work reliably. Moreover, the length of any of these members can be tuned/selected so as to match the implant mounted to the delivery system 100 and coordinate with its intended delivery action (e.g., simple linear deployment vs. the doubling-over approach described above).


Actually, in one variation, delivery system 100 can be configured to work without the bands at all. Specifically, braid section 46 can be tuned such that it severs as the only cover expander/expansion means necessary to effect release.


Whatever element(s) define as expansion means, treatment of the cover merits discussion itself. In some cases, the covers may simply be heat-shrunk down to the implant. As shown in FIG. 5A, however, it may be desirable to add perforations 130 (e.g., with a pin, laser or otherwise) to provide a weakened section or section(s) in the cover 36 to promote controlled rupture. In another approach, the cover 36 includes a notch or slit 132 to provide a point from which an intentional tear can propagate as shown in FIG. 5B. While not shown, the cover could alternatively be scored to a partial depth. Other options are possible as well.



FIG. 6 illustrates another detail relevant to consistent release performance in wedge-based variations of the subject invention. Namely, a gap “G” is advantageously provided between the proximal end of the implant and any jacket 32 and/or liner 28 that would interfere with wedge member 26 withdrawal past the end of the implant. Allowing the wedge to (at least partially) pass beyond the implant during actuation ensures that cover 36 opens to fully release the implant. The length of the gap will typically be between about 1 mm to about 2 mm to ensure desired action.


Also important is the amount of expansion that the wedge member(s) provide. Generally, expansion is at least about 0.004 inches but more typically about 0.006 to about 0.012 inches. While more expansion/interference may be desired in some cases, care should be taken not to introduce other system performance issues in maximizing the size of the wedge body (e.g., hindering crossing profile, mechanical advantage in addressing the cover or generating other interference issues).


Note also, it may be desirable to introduce a chamfer or lead-in to the wedge to assist its introduction under the covered portion of the implant. However, no such feature has been observed as necessary when the components are sized appropriately. It may be preferred (at least in variations of the invention in which a single wedge body is employed) to minimize the wedge member length (e.g., size it to about 0.010 inches or less) to avoid significant effects on system flex performance. In any case, selecting and tuning the size, shape and performance of the constituent parts of the subject systems is within the knowledge of those with skill in the art.


Beyond such routine development considerations, the present invention includes additional exemplary architectures. Of these, delivery system 140 illustrated in FIG. 7 is essentially a one-sided variation of system 100 illustrated in FIGS. 3A-3C. More particularly, it uses a single wedge member 26 and expandable braid section 142 working together to effect cover release. The architecture also closely resembles that of delivery system 10 illustrated in FIG. 1A. However, core member 144 in the case of system 140 in FIG. 7 actually connects to the distal end of the braid. This connection 146 can be made by soldering, welding, gluing, etc.



FIG. 8 shows another one-sided wedge-plus-braid expander type delivery system. In this configuration, delivery system 150 wedge member 152 is set distal to the braid expander section 154.


As another option (equally applicable to other systems as described herein), the expander section of braid need not comprise an extension of braid defining shaft 156. Rather, the shaft may comprise a hypotube sleeve 158 and liner 160, with the expander braid captured external thereto by an extension of cover 162 heat-shrink tube. Other attachment approach are possible as well.


The inclusion of coil 164 (e.g. comprising Stainless Steel or Nitinol ribbon) is also a notable feature. It serves as compressible buttresses to the expander braid layer to in generate a firm lock for the implant between the braid layer and cover.


In delivery system 150, the wedge 152 may comprise a solder joint attaching the core member to the braid. Alternatively, it may comprise a weld joint between the bodies and/or be supplemented with a band to help define a consistent geometry. In any case, the architecture of system 150 may offer advantages in action by first progressively expanding the cover with the braid and then “finish” by drawing the wedge under the implant to ensure the sheath opens for implant release.


In lieu of what one could call “belt-and-suspenders” approaches as taught in connection with FIGS. 7 and 8, the systems in FIGS. 9 and 10 rely only on braid-based expander members. Delivery system 170 illustrated in FIG. 9 is, in essence, a wedgeless version of system 140 illustrated in FIG. 7. As such, release action relies on braid expansion member 142 alone. Likewise, delivery system 180 as shown in FIG. 10 is analogous to delivery system 150 illustrated in FIG. 8, except that the braid and core member termination feature 182 is not sized to provide any wedging action to aid in cover release. In these systems, avoiding the “bump” otherwise present with a wedge member may help achieve more desirable crossing profiles. However, it may require heavier braid construction than embodiments that include one or more wedge features.


The final delivery system architecture illustrated here is shown in FIGS. 11A and 11B. The figures show delivery system 190 before and after implant deployment. In one sense, delivery system 190 operates like braid-expander systems 170 and 180 in that it uses changing angles of a compressed member to drive cover release. However, it is implemented with a compactable coil 192. Advantageously, the coil is isolated from moving across implant 12 by braid layer 32. In use, coil 192 is drawn down by core member 144 so its angle flattens to consequentially expand implant 10 and force cover 26 to open.


Apart from these various device architectures provided (in part) to enable the full generic scope of any of the appended claims, specific methods are still contemplated within the invention. An important application of the subject devices is presented in FIGS. 12A-12D.


In these figures, pertinent implant deployment steps are illustrated in connection with treating a cerebral aneurysm. In this case, a sidewall aneurysm 200 has formed off of an artery 202. After removal from sterile packaging (not shown), and loading the delivery system 210 in a microcatheter 212 that has accessed a target site, the implant 214 is exposed as illustrated in FIG. 12A. To do so, the implant pusher (hidden in FIG. 12A) is typically held stationary, and the microcatheter withdrawn. Microcatheter withdrawal is continued until the entire implant 214 is exposed, attached to pusher 216 by cover 218 as shown in FIG. 12B. Then, the core member within the delivery system is withdrawn to rupture the cover as shown in FIG. 12C. After a quarter turn or straight withdrawal, the implant is free of the delivery system and implantation procedure complete as shown in FIG. 12D.


The subject methods may include each of the physician activities associated with implant positioning and release. As such, methodology implicit to the positioning and deployment of an implant device forms part of the invention. Such methodology may include navigating or tracking an implant through a catheter to a treatment site. In some methods, the various acts of implant introduction adjacent to an aneurysm considered. Other methods concern the manner in which the system is prepared for delivering an implant, for example attaching the implant to the delivery system. Any method herein may be carried out in any order of the recited events which is logically possible, as well as in the recited order of events, or slight modifications of those events or the event order.


Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Reference to a singular item, includes the possibility that there is a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said,” and “the” include plural referents unless specifically stated otherwise. In other words, use of the articles allow for “at least one” of the subject item in the description above as well as the claims below. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation.


Without the use of such exclusive terminology, the term “comprising” in the claims shall allow for the inclusion of any additional element irrespective of whether a given number of elements are enumerated in the claim, or the addition of a feature could be regarded as transforming the nature of an element set forth in the claims. Except as specifically defined herein, all technical and scientific terms used herein are to be given as broad a commonly understood meaning as possible while maintaining claim validity.


The breadth of the present invention is not to be limited to the examples provided and/or the subject specification, but rather only by the scope of the claim language. Use of the term “invention” herein is not intended to limit the scope of the claims in any manner. Rather it should be recognized that the “invention” includes the many variations explicitly or implicitly described herein, including those variations that would be obvious to one of ordinary skill in the art upon reading the present specification. Further, it is not intended that any section of this specification (e.g., summary, detailed description, abstract, field of the invention) be accorded special significance in describing the invention relative to another or the claims. All references cited are incorporated by reference in their entirety. Although the foregoing invention has been described in detail for purposes of clarity of understanding, it is contemplated that certain modifications may be practiced within the scope of the appended claims.

Claims
  • 1. An implant delivery system comprising: a tubular braid implant having proximal and distal ends;an elongate sleeve;a core member carrying a plurality of expanders underlying the implant:the proximal end of the implant constrained radially between a braid section of the sleeve and a proximal cover;the distal end of the implant being constrained radially between the braid section of the sleeve and a distal cover, separate and distinct from the proximal cover,wherein the braid section is expandable by withdrawal of the core member, and the proximal cover and distal cover are each openable by a force from movement of the plurality of underlying expanders against the braid section;wherein the plurality of expanders are axially between the proximal cover and the distal cover, and the plurality of expanders are movable under the braid section, the proximal cover, and the distal cover by withdrawal of the core member.
  • 2. The system of claim 1, wherein the cover is adapted to open by tearing.
  • 3. The system of claim 1, wherein the cover is adapted to open by rupturing.
  • 4. The system of claim 1, wherein each of the expanders comprises a wedge body.
  • 5. The system of claim 4, wherein the wedge body comprises a plurality of bands.
  • 6. The system of claim 1, wherein each of the expanders comprises a coil.
  • 7. The system of claim 1, wherein an atraumatic tip is mounted to the core member.
  • 8. The system of claim 1, wherein the core member comprises a material selected from a group consisting of metal wire and polymeric filament.
  • 9. The system of claim 1, wherein the core member comprises a metal wire, and a coil is affixed thereto under at least a proximal, covered end of the implant.
  • 10. The system of claim 1, further comprising a jacket over a distal portion of the braid section.
  • 11. The system of claim 1, further comprising a jacket under the distal end of the implant.
  • 12. The system of claim 1, wherein a middle section of the implant is neither covered by the proximal cover nor covered by the distal cover.
  • 13. The system of claim 1, wherein the at least a portion of the expanders has a diameter greater than a section proximal to the at least a portion of the expanders.
  • 14. The system of claim 1, wherein, after withdrawal of the core member to expand the braid section, the braid section is more expanded at a location that is over the plurality of underlying expanders, and the braid section is less expanded at a location that is not over the plurality of underlying expanders.
RELATED APPLICATIONS

The present filing claims the benefit of each of U.S. Patent Application Ser. Nos. 61/052,756 filed May 13, 2008 and 61/083,959 filed Jul. 28, 2008—each of which is incorporated herein by reference in its entirety.

US Referenced Citations (590)
Number Name Date Kind
4321711 Mano Mar 1982 A
4503569 Dotter Mar 1985 A
4512338 Balko et al. Apr 1985 A
4538622 Samson et al. Sep 1985 A
4580568 Gianturco Apr 1986 A
4655771 Wallsten Apr 1987 A
4733665 Palmaz Mar 1988 A
4768507 Fischell et al. Sep 1988 A
4776337 Palmaz Oct 1988 A
4954126 Wallsten Sep 1990 A
4998539 Delsanti Mar 1991 A
5011488 Ginsburg Apr 1991 A
5026377 Burton Jun 1991 A
5035706 Giantureo et al. Jul 1991 A
5061275 Wallsten et al. Oct 1991 A
5064435 Porter Nov 1991 A
5108416 Ryan et al. Apr 1992 A
5147370 McNamara et al. Sep 1992 A
5160341 Brenneman et al. Nov 1992 A
5180368 Garrison Jan 1993 A
5192297 Hull Mar 1993 A
5201757 Heyn et al. Apr 1993 A
5209731 Sterman et al. May 1993 A
5222971 Willard et al. Jun 1993 A
5242399 Lau et al. Sep 1993 A
5246420 Kraus et al. Sep 1993 A
5246445 Yachia et al. Sep 1993 A
5334210 Gianturco Aug 1994 A
5344426 Lau et al. Sep 1994 A
5360443 Barone et al. Nov 1994 A
5378239 Termin et al. Jan 1995 A
5382259 Phelps et al. Jan 1995 A
5401257 Chevalier, Jr. et al. Mar 1995 A
5405380 Gianotti et al. Apr 1995 A
5415637 Khosravi May 1995 A
5421826 Crocker et al. Jun 1995 A
5423849 Engelson et al. Jun 1995 A
5445646 Euteneuer et al. Aug 1995 A
5449372 Schmaltz et al. Sep 1995 A
5458615 Klemm et al. Oct 1995 A
5476505 Limon Dec 1995 A
5480423 Ravenscroft et al. Jan 1996 A
5484444 Braunschweiler et al. Jan 1996 A
5489295 Piplani et al. Feb 1996 A
5503636 Schmitt et al. Apr 1996 A
5507768 Lau et al. Apr 1996 A
5522822 Phelps et al. Jun 1996 A
5534007 St. Germain et al. Jul 1996 A
5549635 Solar Aug 1996 A
5562641 Flomenblit et al. Oct 1996 A
5562728 Lazarus et al. Oct 1996 A
5591225 Okuda Jan 1997 A
5599291 Balbierz et al. Feb 1997 A
5607466 Imbert et al. Mar 1997 A
5609625 Piplani et al. Mar 1997 A
5626602 Gianotti et al. May 1997 A
5628783 Quiachon et al. May 1997 A
5632772 Alcime et al. May 1997 A
5636641 Fariabi Jun 1997 A
5643278 Wijay Jul 1997 A
5662703 Yurek et al. Sep 1997 A
5667522 Flomenblit et al. Sep 1997 A
5674276 Andersen et al. Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5690120 Jacobsen et al. Nov 1997 A
5690644 Yurek et al. Nov 1997 A
5695499 Helgerson et al. Dec 1997 A
5700269 Pinchuk et al. Dec 1997 A
5702418 Ravenscroft Dec 1997 A
5709702 Cogita Jan 1998 A
5709703 Lukic et al. Jan 1998 A
5725552 Kotula et al. Mar 1998 A
5725570 Heath Mar 1998 A
5725571 Imbert et al. Mar 1998 A
5733294 Forber et al. Mar 1998 A
5733327 Igaki et al. Mar 1998 A
5735859 Fischell et al. Apr 1998 A
5741325 Chaikof et al. Apr 1998 A
5741333 Frid Apr 1998 A
5749883 Halpern May 1998 A
5749891 Ken et al. May 1998 A
5749919 Blanc May 1998 A
5749920 Quiachon et al. May 1998 A
5769884 Solovay Jun 1998 A
5769885 Quiachon et al. Jun 1998 A
5776099 Tremulis Jul 1998 A
5776140 Cottone Jul 1998 A
5776141 Klein et al. Jul 1998 A
5776142 Gunderson Jul 1998 A
5782909 Quiachon et al. Jul 1998 A
5797952 Klein Aug 1998 A
5800518 Piplani et al. Sep 1998 A
5807398 Shaknovich Sep 1998 A
5810837 Hofmann et al. Sep 1998 A
5814062 Sepetka et al. Sep 1998 A
5817102 Johnson et al. Oct 1998 A
5824039 Piplani et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5824044 Quiachon et al. Oct 1998 A
5824058 Ravenscroft et al. Oct 1998 A
5833632 Jacobsen et al. Nov 1998 A
5836868 Ressemann et al. Nov 1998 A
5846261 Kotula et al. Dec 1998 A
5868754 Levine et al. Feb 1999 A
5873907 Frantzen Feb 1999 A
5888201 Stinson et al. Mar 1999 A
5902266 Leone et al. May 1999 A
5906640 Penn et al. May 1999 A
5911717 Jacobsen et al. Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5916235 Guglielmi Jun 1999 A
5919204 Lukic et al. Jul 1999 A
5925060 Forber Jul 1999 A
5928260 Chin et al. Jul 1999 A
5935148 Villar et al. Aug 1999 A
5944726 Blaeser et al. Aug 1999 A
5944738 Amplatz et al. Aug 1999 A
5951599 McCrory Sep 1999 A
5957973 Quiachon et al. Sep 1999 A
5957974 Thompson et al. Sep 1999 A
5964797 Ho Oct 1999 A
5972015 Scribner et al. Oct 1999 A
5980530 Willard et al. Nov 1999 A
5980533 Holman Nov 1999 A
5980554 Lenker et al. Nov 1999 A
5984929 Bashiri et al. Nov 1999 A
6014919 Jacobsen et al. Jan 2000 A
6015432 Rakos et al. Jan 2000 A
6017319 Jacobsen et al. Jan 2000 A
6019778 Wilson et al. Feb 2000 A
6019786 Thompson Feb 2000 A
6022369 Jacobsen et al. Feb 2000 A
6024754 Engelson Feb 2000 A
6024763 Lenker et al. Feb 2000 A
6027516 Kolobow et al. Feb 2000 A
6033423 Ken et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6039758 Quiachon et al. Mar 2000 A
6042589 Marianne Mar 2000 A
6051021 Frid Apr 2000 A
6056993 Leidner et al. May 2000 A
6063070 Eder May 2000 A
6063104 Villar et al. May 2000 A
6063111 Hieshima et al. May 2000 A
6068634 Lorentzen Cornelius et al. May 2000 A
6074407 Levine et al. Jun 2000 A
6077295 Limon et al. Jun 2000 A
6086577 Ken et al. Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096052 Callister et al. Aug 2000 A
6102942 Ahari Aug 2000 A
6113607 Lau et al. Sep 2000 A
6123712 Di Caprio et al. Sep 2000 A
6123715 Amplatz Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6132459 Piplani et al. Oct 2000 A
6139543 Esch et al. Oct 2000 A
6139564 Teoh Oct 2000 A
6146415 Fitz Nov 2000 A
6149680 Shelso et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6165178 Bashiri et al. Dec 2000 A
6168592 Kupiecki et al. Jan 2001 B1
6168615 Ken et al. Jan 2001 B1
6168618 Frantzen Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6183410 Jacobsen et al. Feb 2001 B1
6190402 Horton et al. Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
6197046 Piplani et al. Mar 2001 B1
6206868 Parodi Mar 2001 B1
6210400 Hebert et al. Apr 2001 B1
6210434 Quiachon et al. Apr 2001 B1
6210435 Piplani et al. Apr 2001 B1
6214038 Piplani et al. Apr 2001 B1
6214042 Jacobsen et al. Apr 2001 B1
6221086 Forber Apr 2001 B1
6221102 Baker et al. Apr 2001 B1
6224609 Ressemann et al. May 2001 B1
6224829 Piplani et al. May 2001 B1
6231597 Deem et al. May 2001 B1
6235050 Quiachon et al. May 2001 B1
6241758 Cox Jun 2001 B1
6241759 Piplani et al. Jun 2001 B1
6245103 Stinson Jun 2001 B1
6251132 Ravenscroft et al. Jun 2001 B1
6260458 Jacobsen et al. Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6270523 Herweck et al. Aug 2001 B1
6280465 Cryer Aug 2001 B1
6287331 Heath Sep 2001 B1
6290721 Heath Sep 2001 B1
6302810 Yokota Oct 2001 B2
6302893 Limon et al. Oct 2001 B1
6322576 Wallace et al. Nov 2001 B1
6322586 Monroe et al. Nov 2001 B1
6322587 Quiachon et al. Nov 2001 B1
6331184 Abrams Dec 2001 B1
6342068 Thompson Jan 2002 B1
6344041 Kupiecki et al. Feb 2002 B1
6344048 Chin et al. Feb 2002 B1
6346117 Greenhalgh Feb 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350199 Williams et al. Feb 2002 B1
6350270 Roue Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6355061 Quiachon et al. Mar 2002 B1
6368339 Amplatz Apr 2002 B1
6368344 Fitz Apr 2002 B1
6368557 Piplani et al. Apr 2002 B1
6371928 Mcfann et al. Apr 2002 B1
6375668 Gifford et al. Apr 2002 B1
6375670 Greenhalgh Apr 2002 B1
6375676 Cox Apr 2002 B1
6379618 Piplani et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6383174 Eder May 2002 B1
6387118 Hanson May 2002 B1
6391037 Greenhalgh May 2002 B1
6395017 Dwyer et al. May 2002 B1
6395022 Piplani et al. May 2002 B1
6398802 Yee Jun 2002 B1
6409683 Fonseca et al. Jun 2002 B1
6413235 Parodi Jul 2002 B1
6416536 Yee Jul 2002 B1
6428489 Jacobsen et al. Aug 2002 B1
6428558 Jones et al. Aug 2002 B1
6432130 Hanson Aug 2002 B1
6440088 Jacobsen et al. Aug 2002 B1
6443971 Boylan et al. Sep 2002 B1
6443979 Stalker et al. Sep 2002 B1
6447531 Amplatz Sep 2002 B1
6451025 Jervis Sep 2002 B1
6454780 Wallace Sep 2002 B1
6454999 Farhangnia et al. Sep 2002 B1
6468266 Bashiri et al. Oct 2002 B1
6478778 Jacobsen et al. Nov 2002 B1
6482221 Hebert et al. Nov 2002 B1
6491648 Cornish et al. Dec 2002 B1
6503450 Afzal et al. Jan 2003 B1
6506204 Mazzocchi Jan 2003 B2
6511468 Cragg et al. Jan 2003 B1
6514261 Randall et al. Feb 2003 B1
6520983 Colgan et al. Feb 2003 B1
6524299 Tran et al. Feb 2003 B1
6527763 Esch et al. Mar 2003 B2
6533811 Ryan et al. Mar 2003 B1
6540778 Quiachon et al. Apr 2003 B1
6547779 Levine et al. Apr 2003 B2
6547804 Porter et al. Apr 2003 B2
6551303 Van Tassel et al. Apr 2003 B1
6572646 Boylan et al. Jun 2003 B1
6576006 Limon et al. Jun 2003 B2
6579303 Amplatz Jun 2003 B2
6582460 Cryer Jun 2003 B1
6585748 Jeffree Jul 2003 B1
6589236 Wheelock et al. Jul 2003 B2
6589256 Forber Jul 2003 B2
6589265 Palmer et al. Jul 2003 B1
6589273 McDermott Jul 2003 B1
6592616 Stack et al. Jul 2003 B1
6599308 Amplatz Jul 2003 B2
6602280 Chobotov Aug 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6605110 Harrison Aug 2003 B2
6605111 Bose et al. Aug 2003 B2
6607539 Hayashi et al. Aug 2003 B1
6607551 Sullivan et al. Aug 2003 B1
6613074 Mitelberg et al. Sep 2003 B1
6613075 Healy et al. Sep 2003 B1
6623518 Thompson et al. Sep 2003 B2
6626939 Burnside et al. Sep 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6638243 Kupiecki Oct 2003 B2
6645240 Yee Nov 2003 B2
6646218 Campbell et al. Nov 2003 B1
6652508 Griffin et al. Nov 2003 B2
6652556 VanTassel et al. Nov 2003 B1
6656212 Ravenscroft et al. Dec 2003 B2
6656218 Denardo et al. Dec 2003 B1
6660024 Flaherty et al. Dec 2003 B1
6663666 Quiachon et al. Dec 2003 B1
6666882 Bose et al. Dec 2003 B1
6669719 Wallace et al. Dec 2003 B2
6669721 Bose et al. Dec 2003 B1
6673089 Yassour et al. Jan 2004 B1
6673100 Diaz et al. Jan 2004 B2
6679893 Tran Jan 2004 B1
6682546 Amplatz Jan 2004 B2
6682557 Quiachon et al. Jan 2004 B1
6685735 Ahari Feb 2004 B1
6689162 Thompson Feb 2004 B1
6689486 Ho et al. Feb 2004 B2
6699274 Stinson Mar 2004 B2
6709454 Cox et al. Mar 2004 B1
6712834 Yassour et al. Mar 2004 B2
6716238 Elliott Apr 2004 B2
6726700 Levine Apr 2004 B1
6730108 Van Tassel et al. May 2004 B2
6733519 Lashinski et al. May 2004 B2
6740105 Yodfat et al. May 2004 B2
6740112 Yodfat et al. May 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6746468 Sepetka et al. Jun 2004 B1
6746890 Gupta et al. Jun 2004 B2
6755855 Yurek et al. Jun 2004 B2
6758885 Leffel et al. Jul 2004 B2
6767361 Quiachon et al. Jul 2004 B2
6773446 Dwyer et al. Aug 2004 B1
6780196 Chin et al. Aug 2004 B2
6793667 Hebert et al. Sep 2004 B2
6802851 Jones et al. Oct 2004 B2
6811560 Jones et al. Nov 2004 B2
6814748 Baker et al. Nov 2004 B1
6818006 Douk et al. Nov 2004 B2
6833003 Jones et al. Dec 2004 B2
6849084 Rabkin et al. Feb 2005 B2
6855153 Saadat Feb 2005 B2
6858034 Hijlkema et al. Feb 2005 B1
6860893 Wallace et al. Mar 2005 B2
6860898 Stack et al. Mar 2005 B2
6860901 Baker et al. Mar 2005 B1
6866677 Douk et al. Mar 2005 B2
6866680 Yassour et al. Mar 2005 B2
6887267 Dworschak et al. May 2005 B2
6890337 Feeser et al. May 2005 B2
6936055 Ken et al. Aug 2005 B1
6955685 Escamilla et al. Oct 2005 B2
6960227 Jones et al. Nov 2005 B2
6964670 Shah et al. Nov 2005 B1
6976991 Hebert et al. Dec 2005 B2
6989024 Hebert et al. Jan 2006 B2
6994092 Van der Burg et al. Feb 2006 B2
6994717 Kónya et al. Feb 2006 B2
6994721 Israel Feb 2006 B2
7001422 Escamilla et al. Feb 2006 B2
7004964 Thompson et al. Feb 2006 B2
7011671 Welch Mar 2006 B2
7011675 Hemerick et al. Mar 2006 B2
7029487 Greene, Jr. et al. Apr 2006 B2
7037330 Rivelli, Jr. et al. May 2006 B1
7066951 Chobotov Jun 2006 B2
7069835 Nishri et al. Jul 2006 B2
7074236 Rabkin et al. Jul 2006 B2
7083632 Avellanet et al. Aug 2006 B2
7093527 Rapaport et al. Aug 2006 B2
7101392 Heath Sep 2006 B2
7107105 Bjorklund et al. Sep 2006 B2
7118539 Vrba et al. Oct 2006 B2
7118594 Quiachon et al. Oct 2006 B2
7122050 Randall et al. Oct 2006 B2
7125419 Sequin et al. Oct 2006 B2
7128073 van der Burg et al. Oct 2006 B1
7128736 Abrams et al. Oct 2006 B1
7137990 Hebert et al. Nov 2006 B2
7166125 Baker et al. Jan 2007 B1
7169170 Widenhouse Jan 2007 B2
7169172 Levine et al. Jan 2007 B2
7169177 Obara Jan 2007 B2
7172617 Colgan et al. Feb 2007 B2
7195636 Avellanet et al. Mar 2007 B2
7195639 Quiachon et al. Mar 2007 B2
7195648 Jones et al. Mar 2007 B2
7201768 Diaz et al. Apr 2007 B2
7201769 Jones et al. Apr 2007 B2
7211109 Thompson May 2007 B2
7213495 McCullagh et al. May 2007 B2
7229461 Chin et al. Jun 2007 B2
7232461 Ramer Jun 2007 B2
7235096 Van Tassel et al. Jun 2007 B1
7264632 Wright et al. Sep 2007 B2
7275471 Nishri et al. Oct 2007 B2
7279005 Stinson Oct 2007 B2
7279208 Goffena et al. Oct 2007 B1
7294137 Rivelli, Jr. et al. Nov 2007 B2
7294146 Chew et al. Nov 2007 B2
7300456 Andreas et al. Nov 2007 B2
7300460 Levine et al. Nov 2007 B2
7306624 Yodfat et al. Dec 2007 B2
7309351 Escamilla et al. Dec 2007 B2
7311031 McCullagh et al. Dec 2007 B2
7320702 Hammersmark et al. Jan 2008 B2
7331973 Gesswein et al. Feb 2008 B2
7331976 McGuckin, Jr. et al. Feb 2008 B2
7331980 Dubrul et al. Feb 2008 B2
7331985 Thompson et al. Feb 2008 B2
7338518 Chobotov Mar 2008 B2
7419503 Pulnev et al. Sep 2008 B2
7468070 Henry et al. Dec 2008 B2
7470282 Shelso Dec 2008 B2
7473271 Gunderson Jan 2009 B2
7491224 Cox et al. Feb 2009 B2
7578826 Gandhi et al. Aug 2009 B2
7597704 Frazier et al. Oct 2009 B2
7785361 Nikolchev et al. Aug 2010 B2
7862602 Licata et al. Jan 2011 B2
8114154 Righini et al. Feb 2012 B2
8147534 Berez et al. Apr 2012 B2
8192480 Tieu et al. Jun 2012 B2
8206431 Seppala et al. Jun 2012 B2
8236042 Berez et al. Aug 2012 B2
8257421 Berez et al. Sep 2012 B2
8267985 Garcia et al. Sep 2012 B2
8273101 Garcia et al. Sep 2012 B2
20010000797 Mazzocchi May 2001 A1
20010012949 Forber Aug 2001 A1
20010012961 Deem et al. Aug 2001 A1
20010049547 Moore Dec 2001 A1
20020013618 Marotta et al. Jan 2002 A1
20020062091 Jacobsen et al. May 2002 A1
20020078808 Jacobsen et al. Jun 2002 A1
20020087119 Parodi Jul 2002 A1
20020099405 Yurek et al. Jul 2002 A1
20020120323 Thompson et al. Aug 2002 A1
20020143384 Ozasa Oct 2002 A1
20020165572 Saadat Nov 2002 A1
20020169473 Sepetka et al. Nov 2002 A1
20020188341 Elliott Dec 2002 A1
20030028209 Teoh et al. Feb 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030069522 Jacobsen et al. Apr 2003 A1
20030100945 Yodfat et al. May 2003 A1
20030109887 Galdonik et al. Jun 2003 A1
20030135258 Andreas et al. Jul 2003 A1
20030149465 Heidner et al. Aug 2003 A1
20030163155 Haverkost et al. Aug 2003 A1
20030163156 Hebert et al. Aug 2003 A1
20030171739 Murphy et al. Sep 2003 A1
20030195553 Wallace et al. Oct 2003 A1
20030199913 Dubrul et al. Oct 2003 A1
20030208256 DiMatteo et al. Nov 2003 A1
20030216693 Mickley Nov 2003 A1
20040015224 Armstrong Jan 2004 A1
20040024416 Yodfat et al. Feb 2004 A1
20040044391 Porter Mar 2004 A1
20040044395 Nelson Mar 2004 A1
20040049204 Harari et al. Mar 2004 A1
20040049256 Yee Mar 2004 A1
20040059407 Escamilla et al. Mar 2004 A1
20040073300 Chouinard et al. Apr 2004 A1
20040078071 Escamilla et al. Apr 2004 A1
20040093010 Gesswein et al. May 2004 A1
20040093063 Wright et al. May 2004 A1
20040098028 Martinez May 2004 A1
20040122468 Yodfat et al. Jun 2004 A1
20040127912 Rabkin et al. Jul 2004 A1
20040138733 Weber et al. Jul 2004 A1
20040143286 Johnson et al. Jul 2004 A1
20040186551 Kao et al. Sep 2004 A1
20040186562 Cox Sep 2004 A1
20040193178 Nikolchev Sep 2004 A1
20040193179 Nikolchev Sep 2004 A1
20040193206 Gerberding et al. Sep 2004 A1
20040199243 Yodfat Oct 2004 A1
20040204749 Gunderson Oct 2004 A1
20040215332 Frid Oct 2004 A1
20040220585 Nikolchev Nov 2004 A1
20050010281 Yodfat et al. Jan 2005 A1
20050033408 Jones et al. Feb 2005 A1
20050033409 Burke et al. Feb 2005 A1
20050049668 Jones et al. Mar 2005 A1
20050049670 Jones et al. Mar 2005 A1
20050090890 Wu et al. Apr 2005 A1
20050096728 Ramer May 2005 A1
20050096732 Marotta et al. May 2005 A1
20050107823 Leone et al. May 2005 A1
20050131523 Bashiri et al. Jun 2005 A1
20050137680 Ortiz et al. Jun 2005 A1
20050209672 George et al. Sep 2005 A1
20050209674 Kutscher Sep 2005 A1
20050228434 Amplatz et al. Oct 2005 A1
20050246010 Alexander et al. Nov 2005 A1
20050267568 Berez et al. Dec 2005 A1
20050283220 Gobran et al. Dec 2005 A1
20050283222 Betelia et al. Dec 2005 A1
20050288764 Snow et al. Dec 2005 A1
20050288766 Plain et al. Dec 2005 A1
20060025845 Escamilla et al. Feb 2006 A1
20060036309 Hebert et al. Feb 2006 A1
20060052815 Fitz et al. Mar 2006 A1
20060052816 Bates et al. Mar 2006 A1
20060058865 Case et al. Mar 2006 A1
20060064151 Guterman et al. Mar 2006 A1
20060089703 Escamilla et al. Apr 2006 A1
20060095213 Escamilla et al. May 2006 A1
20060111771 Ton et al. May 2006 A1
20060116714 Sepetka et al. Jun 2006 A1
20060116750 Hebert et al. Jun 2006 A1
20060155323 Porter et al. Jul 2006 A1
20060167494 Suddaby Jul 2006 A1
20060184238 Kaufmann et al. Aug 2006 A1
20060190076 Taheri Aug 2006 A1
20060206200 Garcia et al. Sep 2006 A1
20060206201 Garcia et al. Sep 2006 A1
20060212127 Karabey et al. Sep 2006 A1
20060235464 Avellanet et al. Oct 2006 A1
20060235501 Igaki Oct 2006 A1
20060247680 Amplatz et al. Nov 2006 A1
20060271149 Berez et al. Nov 2006 A1
20060271153 Garcia et al. Nov 2006 A1
20070021816 Rudin Jan 2007 A1
20070043419 Nikolchev et al. Feb 2007 A1
20070055339 George et al. Mar 2007 A1
20070073379 Chang Mar 2007 A1
20070088387 Eskridge et al. Apr 2007 A1
20070100414 Licata et al. May 2007 A1
20070106311 Wallace et al. May 2007 A1
20070112415 Bartlett May 2007 A1
20070119295 McCullagh et al. May 2007 A1
20070123969 Gianotti May 2007 A1
20070162104 Frid Jul 2007 A1
20070167980 Figulla et al. Jul 2007 A1
20070173928 Morsi Jul 2007 A1
20070191884 Eskridge et al. Aug 2007 A1
20070198075 Levy Aug 2007 A1
20070198076 Hebert et al. Aug 2007 A1
20070203559 Freudenthal et al. Aug 2007 A1
20070203563 Hebert et al. Aug 2007 A1
20070203567 Levy Aug 2007 A1
20070208376 Meng Sep 2007 A1
20070221230 Thompson et al. Sep 2007 A1
20070225760 Moszner et al. Sep 2007 A1
20070225794 Thramann et al. Sep 2007 A1
20070233224 Leynov Oct 2007 A1
20070239261 Bose et al. Oct 2007 A1
20070265656 Amplatz et al. Nov 2007 A1
20070270902 Slazas et al. Nov 2007 A1
20070288083 Hines Dec 2007 A1
20070299500 Hebert et al. Dec 2007 A1
20070299501 Hebert et al. Dec 2007 A1
20070299502 Hebert et al. Dec 2007 A1
20080003354 Nolan Jan 2008 A1
20080009934 Schneider et al. Jan 2008 A1
20080021535 Leopold et al. Jan 2008 A1
20080039933 Yodfat et al. Feb 2008 A1
20080082154 Tseng et al. Apr 2008 A1
20080097495 Feller, III et al. Apr 2008 A1
20080119886 Greenhalgh et al. May 2008 A1
20080154286 Abbott et al. Jun 2008 A1
20080195139 Donald et al. Aug 2008 A1
20080208320 Tan-Malecki et al. Aug 2008 A1
20080219533 Grigorescu Sep 2008 A1
20080221600 Dieck et al. Sep 2008 A1
20080221666 Licata et al. Sep 2008 A1
20080255654 Hebert et al. Oct 2008 A1
20080262590 Murray Oct 2008 A1
20080269774 Garcia et al. Oct 2008 A1
20080281350 Sepetka et al. Nov 2008 A1
20080300667 Hebert et al. Dec 2008 A1
20080319533 Lehe Dec 2008 A1
20090024202 Dave et al. Jan 2009 A1
20090024205 Hebert et al. Jan 2009 A1
20090025820 Adams Jan 2009 A1
20090030496 Kaufmann et al. Jan 2009 A1
20090030497 Metcalf et al. Jan 2009 A1
20090082803 Adams et al. Mar 2009 A1
20090105802 Henry et al. Apr 2009 A1
20090105803 Shelso Apr 2009 A1
20090112251 Qian et al. Apr 2009 A1
20090125093 Hansen May 2009 A1
20090138065 Zhang et al. May 2009 A1
20090163986 Tieu et al. Jun 2009 A1
20090192536 Berez et al. Jul 2009 A1
20090198318 Berez et al. Aug 2009 A1
20090210047 Amplatz et al. Aug 2009 A1
20090264978 Dieck et al. Oct 2009 A1
20090270974 Berez et al. Oct 2009 A1
20090275974 Marchand et al. Nov 2009 A1
20090287241 Berez et al. Nov 2009 A1
20090287288 Berez et al. Nov 2009 A1
20090292348 Berez et al. Nov 2009 A1
20090318947 Garcia et al. Dec 2009 A1
20090319017 Berez et al. Dec 2009 A1
20100030200 Strauss et al. Feb 2010 A1
20100069948 Veznedaroglu et al. Mar 2010 A1
20100152767 Greenhalgh et al. Jun 2010 A1
20100268204 Tieu et al. Oct 2010 A1
20100305606 Gandhi et al. Dec 2010 A1
20100331948 Turovskiy et al. Dec 2010 A1
20110313447 Strauss et al. Dec 2011 A1
20120041470 Strivastava et al. Feb 2012 A1
20120041474 Eckhouse et al. Feb 2012 A1
20120065720 Strauss et al. Mar 2012 A1
20120221095 Berez et al. Aug 2012 A1
20120277784 Berez et al. Nov 2012 A1
20120283765 Berez et al. Nov 2012 A1
20120283815 Berez et al. Nov 2012 A1
20130144380 Quadri et al. Jun 2013 A1
20130172925 Garcia et al. Jul 2013 A1
20130172976 Garcia et al. Jul 2013 A1
Foreign Referenced Citations (50)
Number Date Country
0418677 Mar 1991 EP
442657 Aug 1991 EP
696447 Feb 1996 EP
1369098 Dec 2003 EP
1400219 Mar 2004 EP
1621148 Feb 2006 EP
2143404 Jan 2010 EP
2143460 Jan 2010 EP
10-328216 Dec 1998 JP
11-299901 Nov 1999 JP
2001-509412 Jul 2001 JP
2005-074230 Mar 2005 JP
WO-9509586 Apr 1995 WO
WO 9726939 Jul 1997 WO
WO-9809583 Mar 1998 WO
WO-9902092 Jan 1999 WO
WO 9903404 Jan 1999 WO
WO 9905977 Feb 1999 WO
WO-9949812 Dec 1999 WO
WO 9962432 Dec 1999 WO
WO-0013593 Mar 2000 WO
WO-0105331 Jan 2001 WO
WO 0193782 Dec 2001 WO
WO 0200139 Jan 2002 WO
WO-0228320 Apr 2002 WO
WO-02056798 Jul 2002 WO
WO 02060345 Aug 2002 WO
WO 02071977 Sep 2002 WO
WO-03007840 Jan 2003 WO
WO-03022124 Mar 2003 WO
WO-03049600 Oct 2003 WO
WO-2004010878 Feb 2004 WO
WO-2004030575 Apr 2004 WO
WO 2004066809 Aug 2004 WO
WO 2004087006 Oct 2004 WO
WO 2005018728 Mar 2005 WO
WO-2005030093 Apr 2005 WO
WO 2005117718 Dec 2005 WO
WO 2006026744 Mar 2006 WO
WO 2006052322 May 2006 WO
WO 2006091891 Aug 2006 WO
WO-2006127005 Nov 2006 WO
WO 2007121405 Oct 2007 WO
WO 2008022327 Feb 2008 WO
WO 2008151204 Dec 2008 WO
WO 2008157507 Dec 2008 WO
WO-2005115118 Jul 2009 WO
WO 2009134337 Nov 2009 WO
WO 2010030991 Mar 2010 WO
WO-2011130081 Oct 2011 WO
Non-Patent Literature Citations (28)
Entry
WO, International Search Report, Sep. 3, 2009.
U.S. Appl. No. 60/948,683, filed Jul. 9, 2007.
U.S. Appl. No. 61/044,822, filed Apr. 14, 2008.
PCT/US, 2009/041313 International Search Report, Jan. 14, 2010.
CN, Serial No. 200980114155.5 Office Action, Mar. 29, 2012.
EP, Serial No. 11173658.3 EESR, May 8, 2012.
EP, Serial No. 11173659.1 EESR, May 8, 2012.
EP, Serial No. 11189200.6 EESR, May 8, 2012.
EP, Serial No. 12150960.8 ESR, Jun. 6, 2012.
EP, Serial No. 12150959.0 ESR, Jun. 12, 2012.
EP, Serial No. 11184201.9 EESR, Sep. 5, 2012.
Hill, S., et al., Initial Results of the AMPLATZER® Vascular Plug in the Treatment of Congenital Haert Disease, Business Briefing: US Cardiology 2004.
Ronnen, H. R., AMPLATZER® Vascular Plug Case Study, Closure of Arteriovenous Fistula Between Deep Femoral Artery and Superficial Femoral Vein, AGA Medical Corporation, May 2007.
Benndorf, et al. Treatment of a Ruptured Dissecting Vertebral Artery Aneurysm with Double Stent Placement: Case Report AJNR Am J Neuroradiol, Nov.-Dec. 2001, vol. 22, pp. 1844-1848.
Brilstra, et al., Treatment of Intracranial Aneurysms by Embolization with Coils: A Systematic Review, Stroke, Journal of the American Heart Association, 1999, vol. 30, pp. 470-476.
Ferguson, Gary, Physical Factors in the Initiation, Growth and Rupture of Human Intracranial Saccular Ameurysms, J. Neurosurg, Dec. 1972, vol. 37, pp. 666-667.
Geremia, et al., Embolization of Experimentally Created Aneurysms with Intravascular Stent Devices, ANJR American Journal of Neuroradiology, Aug. 1994, vol. 15, pp. 1223-1231.
Geremia, et al., Occlusion of Experimentally Created Fusiform Aneurysms with Porous Metallic Stents, ANJR Am J Neuroradiol, Apr. 2000, Issue 21, pp. 739-745.
Lanzino, et al., Efficacy and Current Limitations of Intravascular Stents for Intracranial Internal Carotid, Vertebral, and Basilar Artery Aneurysms, Journal of Neurosurgery, Oct. 1999, vol. 91, Issue 4, pp. 538-546.
Lieber, et al., Alteration of Hemodynamics in Aneurysm Models by Stenting: Influence of Stent Porosity, Ann of Biomedical Eng., 1997, vol. 25, pp. 460-469, Buffalo, NY.
Lieber, et al., The Physics of Endoluminal Stenting in the Treatment of Cerebrovascular Aneurysms, Neurological Research, 2002, Vcol 24, Issue Supplement 1, pp. S32-S42.
Moss, et al., Vascular Occlusion with a Balloon-Expadable Stent Occluder, Radiology, May 1994, vol. 191, Issue 2, pp. 483-486.
Pereira, Edgard, History of Endovascular Aneurysm Occlusion, Management of Cerebral Aneurysms, 2004, pp. 11-26.
Qureshi, Adnan, Endovascular Treatment of Cerebrovascular Diseases and Intracranial Neoplasms, The Lancelet, Mar. 2004, vol. 363, pp. 804-813.
Steiger, Pathophysiology of Development and Rupture of Cerebral Aneurysms, Acta Nurochirurgica, Mar. 1990, vol. Supplementum 48, Pages in 62 pages.
Tenaglia, et al., Ultrasound Guide Wire-Directed Stent Deployment, Duke University Medical Center, Department of Medicine, 1993 USA.
Yu, et al., A Steady Flow Analysis on the Stented and Non-Stented Sidewall Aneurysm Models, Medical Engineering and Physics, Apr. 1999, Issue 21, pp. 133-141.
U.S. Appl. No. 13/552,105, filed Jul. 18, 2012.
Related Publications (1)
Number Date Country
20090287292 A1 Nov 2009 US
Provisional Applications (2)
Number Date Country
61052756 May 2008 US
61083959 Jul 2008 US